首页 > 最新文献

Laryngo-rhino-otologie最新文献

英文 中文
Eingriffe an Larynx, Hypopharynx und Trachea. 对喉、下咽和气管进行干预。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2280-9348
J A Werner, J P Windfuhr
{"title":"Eingriffe an Larynx, Hypopharynx und Trachea.","authors":"J A Werner, J P Windfuhr","doi":"10.1055/a-2280-9348","DOIUrl":"10.1055/a-2280-9348","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zu „HNSCC: prognostischer Wert der lymphatischen Metastasengröße eingeschätzt“. 就 "HNSCC:淋巴转移灶大小的预后价值评估 "发表评论。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2298-8010
{"title":"Kommentar zu „HNSCC: prognostischer Wert der lymphatischen Metastasengröße eingeschätzt“.","authors":"","doi":"10.1055/a-2298-8010","DOIUrl":"https://doi.org/10.1055/a-2298-8010","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The adaptive use of the Freiburg monosyllabic speech test in noise with a reduced number of test lists]. [在噪音环境下,使用少量测试清单进行弗莱堡单音节语音测试的适应性应用]。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-02-22 DOI: 10.1055/a-2235-0873
Tobias Memmeler, Rainer Schönweiler, Peter Schlattmann, Jan Löhler

Background: Considering the different calibration and masking of the noise, the adaptive Freiburg monosyllabic speech test in noise (aFBE-S) and the Oldenburg sentence test in noise (OLSA-S) were shown to be comparable with respect to the accuracy of both tests in a previous study. However, the time requirement of the aFBE-S was significantly greater than that of the OLSA-S due to the adaptive measurement method. The purpose of this study is to theoretically determine whether the aFBE-S can be used with fewer test lists, given the low scatter of results, and to compare the results with those of the OLSA-S.

Methods: Using the results of 40 otologically healthy subjects who had already been tested in randomized order with the OLSA-S and aFBE-S, the mean difference of the 95 % confidence interval (95 % CI) of the signal-to-noise ratio for 50% speech understanding (S/N50) of the aFBE-S was calculated for three, four, and five test lists instead of 7.5. In addition, the time required for the reduced number of test lists was determined and the results were examined in comparison with those of the OLSA-S.

Results: In each case, no significant difference between the difference mean of the 95 %-CI of the S/N50 of the original aFBE-S, the aFBE-S shortened to 3, 4, or 5 test lists and the OLSA-S could be found. The time required for the aFBE-S with a reduced number of test lists was significantly less than for the OLSA-S in each case.

Conclusion: The aFBE-S is not inferior with a reduced number of test lists in comparison to the OLSA-S. This would allow to use the shortened aFBE-S theoretically.

背景:考虑到不同的校准和噪声掩蔽,噪声中的自适应弗莱堡单音节语音测试(aFBE-S)和噪声中的奥尔登堡句子测试(OLSA-S)在准确性方面不相上下。然而,由于采用了自适应测量方法,aFBE-S 的时间要求明显高于 OLSA-S。本研究的目的是从理论上确定,鉴于结果的分散性较低,aFBE-S 是否可以使用较少的测试清单,并将其结果与 OLSA-S 的结果进行比较:方法: 使用 40 名耳科健康受试者的结果,这些受试者已按随机顺序接受了 OLSA-S 和 aFBE-S 测试,计算了 aFBE-S 50%语音理解信噪比(S/N50)的 95 % 置信区间(95 % CI)的平均差异,分别为 3、4 和 5 个测试列表,而不是 7.5 个。此外,还确定了减少测试列表数量所需的时间,并将结果与 OLSA-S 的结果进行了比较:在每种情况下,原始 aFBE-S、缩短为 3、4 或 5 个测试列表的 aFBE-S 和 OLSA-S 的 S/N50 的 95 %-CI 的差异平均值之间均无明显差异。在每种情况下,减少测试列表数量的 aFBE-S 所需的时间都明显少于 OLSA-S:结论:与 OLSA-S 相比,减少测试列表数量后的 aFBE-S 并不逊色。结论:与 OLSA-S 相比,减少测试列表数量后的 aFBE-S 并不比 OLSA-S 差,因此理论上可以使用缩短的 aFBE-S。
{"title":"[The adaptive use of the Freiburg monosyllabic speech test in noise with a reduced number of test lists].","authors":"Tobias Memmeler, Rainer Schönweiler, Peter Schlattmann, Jan Löhler","doi":"10.1055/a-2235-0873","DOIUrl":"10.1055/a-2235-0873","url":null,"abstract":"<p><strong>Background: </strong>Considering the different calibration and masking of the noise, the adaptive Freiburg monosyllabic speech test in noise (aFBE-S) and the Oldenburg sentence test in noise (OLSA-S) were shown to be comparable with respect to the accuracy of both tests in a previous study. However, the time requirement of the aFBE-S was significantly greater than that of the OLSA-S due to the adaptive measurement method. The purpose of this study is to theoretically determine whether the aFBE-S can be used with fewer test lists, given the low scatter of results, and to compare the results with those of the OLSA-S.</p><p><strong>Methods: </strong>Using the results of 40 otologically healthy subjects who had already been tested in randomized order with the OLSA-S and aFBE-S, the mean difference of the 95 % confidence interval (95 % CI) of the signal-to-noise ratio for 50% speech understanding (S/N50) of the aFBE-S was calculated for three, four, and five test lists instead of 7.5. In addition, the time required for the reduced number of test lists was determined and the results were examined in comparison with those of the OLSA-S.</p><p><strong>Results: </strong>In each case, no significant difference between the difference mean of the 95 %-CI of the S/N50 of the original aFBE-S, the aFBE-S shortened to 3, 4, or 5 test lists and the OLSA-S could be found. The time required for the aFBE-S with a reduced number of test lists was significantly less than for the OLSA-S in each case.</p><p><strong>Conclusion: </strong>The aFBE-S is not inferior with a reduced number of test lists in comparison to the OLSA-S. This would allow to use the shortened aFBE-S theoretically.</p>","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11219187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liebe Leserinnen und Leser der LRO. 亲爱的 LRO 读者们
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2280-9500
Stefan Dazert
{"title":"Liebe Leserinnen und Leser der LRO.","authors":"Stefan Dazert","doi":"10.1055/a-2280-9500","DOIUrl":"https://doi.org/10.1055/a-2280-9500","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) – Mepolizumab überzeugt in Real-World-Studien. 伴有鼻息肉的慢性鼻炎(CRSwNP)--mepolizumab 在实际研究中令人信服。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2280-9363
{"title":"Chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) – Mepolizumab überzeugt in Real-World-Studien.","authors":"","doi":"10.1055/a-2280-9363","DOIUrl":"https://doi.org/10.1055/a-2280-9363","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zu „Spasmodische Dysphonie: Schmerzwahrnehmung nach Injektion von Botulinumtoxin“. 就 "痉挛性发音障碍:肉毒杆菌毒素注射后的疼痛感 "发表评论。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2226-0970
{"title":"Kommentar zu „Spasmodische Dysphonie: Schmerzwahrnehmung nach Injektion von Botulinumtoxin“.","authors":"","doi":"10.1055/a-2226-0970","DOIUrl":"https://doi.org/10.1055/a-2226-0970","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Basics in diagnostics and therapy of allergic diseases for ENT consultations]. [耳鼻喉科会诊过敏性疾病的诊断和治疗基础]。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2073-9474
Jonas Kornmann, Benedikt Kramer, Daniel Haeussler

Allergies play a pivotal role in the daily practice of ENT specialists. Allergic symptoms induced by inhalant allergens are widespread in the population and can manifest through a wide range of symptoms, including rhinorrhea, sneezing, conjunctival redness, cough and dyspnea. Inconsistent diagnosis and treatment of allergic conditions can lead to reduced quality of life, decreased work performance, and socioeconomically significant secondary diseases. In addition to the medical history, the skin prick test and serological IgE diagnostics are the most important diagnostic procedure for detecting type-I allergies. To clarify clinical relevance, molecular diagnostics and nasal provocation testing may be employed. The key to effective treatment lies in a comprehensive allergological diagnosis coupled with a detailed patient history. General treatment recommendations such as allergen avoidance and nasal irrigation should complement pharmacological therapy. In the treatment of allergic rhinitis topical steroids are first line treatment options. The primary goal of treatment is symptom control, and if control is insufficient, causal therapy through specific allergen immunotherapy is recommended. Challenges in the ENT clinic involve selecting the necessary diagnostics and appropriate, effective treatments. Hence, using diagnostic and treatment algorithms, as well as standardized patient history questionnaires, can serve as invaluable tools in daily patient interactions, especially considering limited time availability.

过敏在耳鼻喉科专家的日常工作中扮演着举足轻重的角色。吸入性过敏原诱发的过敏症状在人群中十分普遍,可表现为各种症状,包括鼻出血、打喷嚏、结膜发红、咳嗽和呼吸困难。对过敏性疾病的诊断和治疗不一致会导致生活质量下降、工作绩效降低,并引发严重的继发性社会经济疾病。除了病史,皮肤点刺试验和血清 IgE 诊断是检测 I 型过敏症最重要的诊断程序。为明确临床相关性,可采用分子诊断和鼻激发试验。有效治疗的关键在于全面的过敏诊断和详细的病史。避免接触过敏原和鼻腔冲洗等一般治疗建议应与药物治疗相辅相成。在过敏性鼻炎的治疗中,外用类固醇是一线治疗方案。治疗的首要目标是控制症状,如果控制效果不佳,建议通过特异性过敏原免疫疗法进行病因治疗。耳鼻喉科诊所面临的挑战包括选择必要的诊断和适当有效的治疗。因此,使用诊断和治疗算法以及标准化的患者病史问卷可作为与患者进行日常交流的宝贵工具,尤其是考虑到时间有限。
{"title":"[Basics in diagnostics and therapy of allergic diseases for ENT consultations].","authors":"Jonas Kornmann, Benedikt Kramer, Daniel Haeussler","doi":"10.1055/a-2073-9474","DOIUrl":"https://doi.org/10.1055/a-2073-9474","url":null,"abstract":"<p><p>Allergies play a pivotal role in the daily practice of ENT specialists. Allergic symptoms induced by inhalant allergens are widespread in the population and can manifest through a wide range of symptoms, including rhinorrhea, sneezing, conjunctival redness, cough and dyspnea. Inconsistent diagnosis and treatment of allergic conditions can lead to reduced quality of life, decreased work performance, and socioeconomically significant secondary diseases. In addition to the medical history, the skin prick test and serological IgE diagnostics are the most important diagnostic procedure for detecting type-I allergies. To clarify clinical relevance, molecular diagnostics and nasal provocation testing may be employed. The key to effective treatment lies in a comprehensive allergological diagnosis coupled with a detailed patient history. General treatment recommendations such as allergen avoidance and nasal irrigation should complement pharmacological therapy. In the treatment of allergic rhinitis topical steroids are first line treatment options. The primary goal of treatment is symptom control, and if control is insufficient, causal therapy through specific allergen immunotherapy is recommended. Challenges in the ENT clinic involve selecting the necessary diagnostics and appropriate, effective treatments. Hence, using diagnostic and treatment algorithms, as well as standardized patient history questionnaires, can serve as invaluable tools in daily patient interactions, especially considering limited time availability.</p>","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kopf-Hals-Tumoren: Schlechterer Outcome nach Bluttransfusion? 头颈部肿瘤:输血后预后更差?
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2262-6093
{"title":"Kopf-Hals-Tumoren: Schlechterer Outcome nach Bluttransfusion?","authors":"","doi":"10.1055/a-2262-6093","DOIUrl":"https://doi.org/10.1055/a-2262-6093","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From the Expert's Office: Voice disorders after COVID without intubation or tracheostomy - fact or fiction?] [来自专家办公室:无插管或气管切开术的 COVID 术后嗓音障碍--事实还是虚构?]
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-02 DOI: 10.1055/a-2308-8400
Wolfgang Angerstein
{"title":"[From the Expert's Office: Voice disorders after COVID without intubation or tracheostomy - fact or fiction?]","authors":"Wolfgang Angerstein","doi":"10.1055/a-2308-8400","DOIUrl":"https://doi.org/10.1055/a-2308-8400","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tularemia - the interesting case]. [图拉雷病--有趣的病例]。
IF 0.9 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-07-01 Epub Date: 2023-12-11 DOI: 10.1055/a-2211-7735
Birgit Didczuneit-Sandhop, Katharina Böhm, Thomas Kalinski, Manja Jolie
{"title":"[Tularemia - the interesting case].","authors":"Birgit Didczuneit-Sandhop, Katharina Böhm, Thomas Kalinski, Manja Jolie","doi":"10.1055/a-2211-7735","DOIUrl":"10.1055/a-2211-7735","url":null,"abstract":"","PeriodicalId":17965,"journal":{"name":"Laryngo-rhino-otologie","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138806607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laryngo-rhino-otologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1